Abstract
Expression of concern: “Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa?” and “Bactericidal antibody against a representative epidemiological meningococcal serogroup”
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have